Biomarkers in melanoma: staging, prognosis and detection of early metastases.
about
Current concepts of metastasis in melanoma.Prognostic relevance of P-cadherin expression in melanocytic skin tumours analysed by high-throughput tissue microarrays.Biomarkers in melanoma: stage III and IV disease.Loss of tumor suppressors KAI1 and p27 identifies a unique subgroup of primary melanoma patients with poor prognosis.Melanoma update: diagnostic and prognostic factors that can effectively shape and personalize management.PAX3d mRNA over 2.76 copies/µL in the bloodstream predicts cutaneous malignant melanoma relapse.
P2860
Biomarkers in melanoma: staging, prognosis and detection of early metastases.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Biomarkers in melanoma: staging, prognosis and detection of early metastases.
@ast
Biomarkers in melanoma: staging, prognosis and detection of early metastases.
@en
type
label
Biomarkers in melanoma: staging, prognosis and detection of early metastases.
@ast
Biomarkers in melanoma: staging, prognosis and detection of early metastases.
@en
prefLabel
Biomarkers in melanoma: staging, prognosis and detection of early metastases.
@ast
Biomarkers in melanoma: staging, prognosis and detection of early metastases.
@en
P2093
P2860
P356
P1476
Biomarkers in melanoma: staging, prognosis and detection of early metastases
@en
P2093
Gerald P Linette
Jeffrey S Ross
Martin C Mihm
P2860
P304
P356
10.1586/14737159.3.3.303
P577
2003-05-01T00:00:00Z